|The RHG9 arhgap9 (Catalog #MBS9405017) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The RHG9 Antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s RHG9 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB).
Western blotting: 1:500~1:3000. Researchers should empirically determine the suitability of the RHG9 arhgap9 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The RHG9 arhgap9 product has the following accession number(s) (GI #122939149) (NCBI Accession #NP_001073625.1) (Uniprot Accession #Q9BRR9). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the RHG9 Antibody with the following immunoassay(s):
Western Blot (WB) (Western blot analysis of extracts from LOVO cells, using RHG9 antibody.)
GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. Has a substantial GAP activity toward CDC42 and RAC1 and less toward RHOA. Has a role in regulating adhesion of hematopoietic cells to the extracellular matrix. Binds phosphoinositides, and has the highest affinity for phosphatidylinositol 3,4,5-trisphosphate, followed by phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 4,5-bisphosphate.Furukawa Y., Biochem. Biophys. Res. Commun. 284:643-649(2001).The MGC Project Team, Genome Res. 14:2121-2127(2004).Kawasoe T., Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
Immunogen Type: Peptide
Immunogen Description: Synthesized peptide derived from internal of human RHG9. Target Name: RHG9. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing RHG9 are readily searchable from our website. Different antibodies against the same target such as RHG9 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. The following patways have been known to be associated with this gene. RHG9 also interacts with the following gene(s): CDC42, RAC1, RHOA. Cardiovascular Diseases, Coronary Vasospasm, Inflammation are some of the diseases may be linked to RHG9 Antibody. Adipose Tissue, Adrenal Gland, Blood, Bone Marrow, Brain, Connective Tissue, Kidney, Lung, Spleen, Thymus tissues are correlated with this protein.